Tvardi Therapeutics, Inc. · NASDAQ:TVRD
Ronald A. DePinho reported a 6.70% stake in Tvardi Therapeutics, Inc. (Schedule 13G/A)
Event Sep 30, 2025 · Filed Nov 14, 2025
Ronald A. DePinho reported a 6.70% stake in Tvardi Therapeutics, Inc., 626,190 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).
- Stake
- 6.70%
- Shares
- 626,190
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Ronald A. DePinho | 6.70% | 626,190 |
Source
Related
- Tvardi Therapeutics, Inc.
- Ronald A. DePinho
- Tvardi Therapeutics, Inc. shareholders
- Schedule 13G/A · Ronald A. DePinho · Feb 17, 2026
- Schedule 13G · Ronald A. DePinho · Jun 2, 2025
- Schedule 13G · Slate Path Capital LP · Aug 14, 2025
- Schedule 13G · Sporos Bioventures LLC · Aug 8, 2025
- Schedule 13G/A · Samuel D. Tweardy · Aug 5, 2025
- Schedule 13G · David J. Tweardy · May 2, 2025
- Schedule 13G · Samuel D. Tweardy · May 2, 2025